Data Science Funding Announcements & Notices

Data science and informatics funding announcements and notices are available from NCI and NIH programs. Browse below for opportunities, requests for information, notices, and initiatives.

Title FOA Organization Release Date Expire Date Purpose
Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 Clinical Trial Optional) PAR-21-138 NCI The National Cancer Institute (NCI) Method to Extend Research in Time (MERIT) (R37) Award provides extended grant support to Early Stage Investigators (ESIs). By providing such an opportunity for… More
Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) RFA-CA-21-008 NCI The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called "competing revisions") from currently funded NCI U01 research projects. The… More
Notice of Intent to Publish: Funding Opportunity Announcement for Human Immune-Representing Oncology Models for Immuno-Oncology Research (R33 Clinical Trial Optional) NOT-CA-19-047 NCI N/A Notice Intent Publish: Funding Opportunity Announcement Human Immune-Representing Oncology Models Immuno-Oncology Research R33 Clinical Trial Optional) Notice Number: NOT-CA-19-047 Key Dates Release… More
Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R21 Clinical Trial Not Allowed) PAR-19-199 NCI The purpose of this Funding Opportunity Announcement (FOA) is to support research which can elucidate mechanism(s) of action by which gut microbes inhibit or enhance anti-tumor immune responses.… More
Notice of Information: FNIH Cancer Steering Committee Project Concepts for Novel Biomarker Platforms in Understanding Tumor Heterogeneity NOT-CA-20-092 NCI N/A Notice Information: FNIH Cancer Steering Committee Project Concepts Novel Biomarker Platforms Understanding Tumor Heterogeneity Notice Number: NOT-CA-20-092 Key Dates Release Date: July 27, 2020… More
The NCI Transition Career Development Award (K22 - Independent Clinical Trial Required) PAR-21-111 NCI This Funding Opportunity Announcement (FOA) represents the continuation of an NCI program to facilitate the transition of investigators in mentored, non-independent cancer research positions to… More
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trial Optional) RFA-CA-21-009 NCI The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called "competing revisions") from currently funded NCI U54 Resource-Related… More
Clinical Translation of Activated Optical Fluorescence Methods and Technologies for Sensitive Cancer Detection in Vivo (R01 Clinical Trial Optional) PAR-20-295 NCI [The purpose of this PAR is to bring a highly sensitivity imaging technology capable of locating very small (1-3 mm) tumors in vivo to clinical utility. Under this funding opportunity, NCI solicits… More
National Cancer Institute Program Project Applications (P01 Clinical Trial Optional) PAR-20-077 NCI With this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications for investigator-initiated Program Project (P01) applications. The proposed Program may… More
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) PAR-19-363 NCI Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) seeks research project (R01) grant applications describing projects that integrate imaging and fluid-based… More
Updated: